Skip to main content
. 2024 Jan 20;48(5):668–673. doi: 10.1038/s41366-023-01457-4

Table 2.

Odds of incident diabetes at 5 years by measured and predicted values for intrahepatic fat and visceral fata.

Oddsb of Incident Diabetes, Odds Ratio [95% CI]
Unadjusted P value Model 1c P value Model 2d P value
Hepatic fat, measured by CT or metabolite score
Intrahepatic fata 1.61 [1.23, 2.10] 4.48e−04 1.65 [1.25, 2.16] 3.26e−04 1.53 [1.13, 2.10] 6.71e−03
MET-Liver 1.91 [1.38, 2.65] 1.1e−04 2.04 [1.46, 2.86] 3.33e−05 2.04 [1.37, 3.03] 3.91e−04
Visceral fat, measured by CT or metabolite score
Visceral fat 1.76 [1.36, 2.27] 1.76e−05 1.86 [1.39, 2.48] 2.44e−05 1.98 [1.26, 3.11] 3.18e−03
MET-Visc 2.23 [1.52, 3.25] 3.46e−05 2.43 [1.67, 3.55] 4.25e−06 2.80 [1.75, 4.46] 1.53e−05
Metabolite-derived adiposity scores adjusted for CT-measured adiposity
MET-Liver, adjusted for Intrahepatic fat 1.87 [1.06, 3.27] 0.03
MET-Visc, adjusted for visceral fat 2.38 [1.34, 4.25] 3.20e−03
Measured visceral fat area adjusted for hepatic attenuation
Intrahepatic fat 1.36 [0.97, 1.92] 0.08
Visceral fat 1.78 [1.08, 2.93] 0.02

aInverse hepatic attenuation in Hounsfield units (HU*-1) visceral fat area (cm2).

bOR by z-score of inverse hepatic attenuation or visceral fat area (cm2).

cAdjusted for age, gender, study site.

dModel 1 + adjustment for BMI (kg/m2), energy intake (kCal/day), Alternative Health Eating Index-2010 (AHEI-2010), physical activity (MET-minutes/week), use of lipid-lowering medications.